Motilal Oswal's research report on SBI Life Insurance
SBILIFE reported decent performance in 3QFY24. APE grew 13% YoY (22% beat), while VNB grew 11% YoY as margins contracted 40bp YoY to 27.4%. PAT grew 6% YoY to INR3.2b (vs. our estimate of INR 4.0b, registering 20% miss). In terms of NBP, Group Savings and ULIPs witnessed a healthy YoY growth of 54% and 16%, respectively, while Par savings declined 17% YoY in 3QFY24. The protection business was flat YoY.
Outlook
We expect SBILIFE to deliver 18% CAGR in APE over FY23-26E, thus enabling a 16.4% VNB CAGR. RoEV is expected to stay at around ~20%. We reiterate our BUY rating on the stock with a TP of INR1,700 (2.3x Sep’26E EV).
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
